Concepts (113)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Docosahexaenoic Acids | 8 | 2014 | 67 | 1.660 |
Why?
|
| Child Development | 7 | 2010 | 266 | 0.850 |
Why?
|
| Milk, Human | 5 | 2009 | 301 | 0.790 |
Why?
|
| Infant Nutritional Physiological Phenomena | 4 | 2009 | 193 | 0.780 |
Why?
|
| Lactation | 2 | 2009 | 193 | 0.520 |
Why?
|
| Breast Feeding | 5 | 2010 | 220 | 0.500 |
Why?
|
| Nutritional Requirements | 4 | 2009 | 181 | 0.490 |
Why?
|
| Psychomotor Performance | 5 | 2010 | 182 | 0.470 |
Why?
|
| Visual Acuity | 2 | 2010 | 816 | 0.420 |
Why?
|
| Infant Formula | 2 | 2009 | 96 | 0.340 |
Why?
|
| Arachidonic Acid | 2 | 2007 | 81 | 0.320 |
Why?
|
| Prenatal Nutritional Physiological Phenomena | 1 | 2006 | 18 | 0.260 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 1 | 2006 | 48 | 0.250 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2006 | 70 | 0.240 |
Why?
|
| Infant, Premature | 1 | 2009 | 817 | 0.220 |
Why?
|
| Fatty Acids, Essential | 1 | 2002 | 5 | 0.200 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2025 | 192 | 0.200 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2002 | 65 | 0.190 |
Why?
|
| Neuropsychological Tests | 5 | 2010 | 925 | 0.190 |
Why?
|
| Gastrointestinal Diseases | 1 | 2025 | 336 | 0.180 |
Why?
|
| Infant, Newborn | 4 | 2009 | 8193 | 0.180 |
Why?
|
| Dietary Supplements | 3 | 2014 | 473 | 0.180 |
Why?
|
| Dietary Fats | 1 | 2002 | 294 | 0.170 |
Why?
|
| Upper Gastrointestinal Tract | 1 | 2018 | 9 | 0.150 |
Why?
|
| Granuloma | 1 | 2018 | 68 | 0.140 |
Why?
|
| Nutrition Policy | 2 | 2009 | 102 | 0.140 |
Why?
|
| Collateral Circulation | 1 | 2017 | 45 | 0.140 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2017 | 44 | 0.140 |
Why?
|
| Stenosis, Pulmonary Vein | 1 | 2017 | 19 | 0.140 |
Why?
|
| Polytetrafluoroethylene | 1 | 2017 | 84 | 0.140 |
Why?
|
| Cognition Disorders | 3 | 2007 | 553 | 0.140 |
Why?
|
| Esophageal and Gastric Varices | 1 | 2017 | 65 | 0.140 |
Why?
|
| Paclitaxel | 1 | 2017 | 130 | 0.130 |
Why?
|
| Infant | 7 | 2017 | 12456 | 0.130 |
Why?
|
| Angioplasty, Balloon | 1 | 2017 | 172 | 0.130 |
Why?
|
| Colitis, Ulcerative | 1 | 2018 | 205 | 0.120 |
Why?
|
| Attention | 2 | 2007 | 202 | 0.120 |
Why?
|
| Retina | 2 | 2009 | 450 | 0.110 |
Why?
|
| Social Skills | 1 | 2014 | 16 | 0.110 |
Why?
|
| Depression, Postpartum | 2 | 2006 | 50 | 0.110 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 2 | 2007 | 224 | 0.110 |
Why?
|
| Child Behavior | 1 | 2014 | 230 | 0.100 |
Why?
|
| Female | 14 | 2025 | 66722 | 0.100 |
Why?
|
| Child, Preschool | 6 | 2018 | 13975 | 0.090 |
Why?
|
| Autistic Disorder | 1 | 2014 | 350 | 0.090 |
Why?
|
| Term Birth | 1 | 2010 | 32 | 0.090 |
Why?
|
| Language Disorders | 2 | 2007 | 24 | 0.080 |
Why?
|
| Communication | 1 | 2014 | 518 | 0.080 |
Why?
|
| Humans | 16 | 2025 | 125040 | 0.080 |
Why?
|
| Fish Oils | 1 | 2009 | 84 | 0.080 |
Why?
|
| Nervous System | 1 | 2009 | 127 | 0.080 |
Why?
|
| Immunity | 1 | 2009 | 191 | 0.070 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2009 | 172 | 0.070 |
Why?
|
| Phospholipids | 2 | 2005 | 106 | 0.070 |
Why?
|
| Language Tests | 2 | 2007 | 24 | 0.070 |
Why?
|
| Prenatal Care | 1 | 2010 | 347 | 0.070 |
Why?
|
| Neurogenesis | 1 | 2009 | 191 | 0.070 |
Why?
|
| Bottle Feeding | 1 | 2007 | 36 | 0.070 |
Why?
|
| Reaction Time | 1 | 2007 | 175 | 0.070 |
Why?
|
| Pregnancy | 3 | 2010 | 7193 | 0.070 |
Why?
|
| Double-Blind Method | 2 | 2014 | 1638 | 0.070 |
Why?
|
| Male | 10 | 2025 | 61438 | 0.060 |
Why?
|
| Fetus | 1 | 2009 | 584 | 0.060 |
Why?
|
| Norepinephrine | 1 | 2006 | 177 | 0.060 |
Why?
|
| Evoked Potentials, Visual | 1 | 2005 | 35 | 0.060 |
Why?
|
| Protein-Losing Enteropathies | 1 | 2025 | 19 | 0.060 |
Why?
|
| Intestinal Pseudo-Obstruction | 1 | 2025 | 29 | 0.060 |
Why?
|
| Visual Perception | 1 | 2006 | 124 | 0.060 |
Why?
|
| Time Factors | 2 | 2017 | 6327 | 0.060 |
Why?
|
| Energy Intake | 1 | 2007 | 493 | 0.060 |
Why?
|
| Mothers | 1 | 2007 | 354 | 0.060 |
Why?
|
| Pancreatitis | 1 | 2025 | 131 | 0.050 |
Why?
|
| Age of Onset | 1 | 2025 | 592 | 0.050 |
Why?
|
| Pregnancy Outcome | 1 | 2006 | 589 | 0.050 |
Why?
|
| Severity of Illness Index | 3 | 2025 | 2905 | 0.050 |
Why?
|
| Cognition | 1 | 2007 | 731 | 0.050 |
Why?
|
| Intellectual Disability | 2 | 2007 | 1056 | 0.050 |
Why?
|
| Infant Food | 1 | 2002 | 81 | 0.050 |
Why?
|
| Child | 6 | 2025 | 24334 | 0.050 |
Why?
|
| Food, Fortified | 1 | 2002 | 96 | 0.050 |
Why?
|
| Vision, Ocular | 1 | 2002 | 122 | 0.050 |
Why?
|
| Pregnancy Complications | 1 | 2006 | 512 | 0.050 |
Why?
|
| Developmental Disabilities | 1 | 2003 | 711 | 0.040 |
Why?
|
| Colectomy | 1 | 2018 | 74 | 0.040 |
Why?
|
| Drug-Eluting Stents | 1 | 2017 | 64 | 0.030 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2017 | 100 | 0.030 |
Why?
|
| Reproducibility of Results | 3 | 2007 | 2887 | 0.030 |
Why?
|
| Coronary Angiography | 1 | 2017 | 444 | 0.030 |
Why?
|
| Animals | 2 | 2009 | 34246 | 0.030 |
Why?
|
| Brain | 1 | 2006 | 2999 | 0.030 |
Why?
|
| Adolescent | 2 | 2025 | 19316 | 0.030 |
Why?
|
| United States | 1 | 2007 | 10904 | 0.020 |
Why?
|
| Sensitivity and Specificity | 2 | 2007 | 2053 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2017 | 2099 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2017 | 5165 | 0.020 |
Why?
|
| Adult | 2 | 2005 | 29625 | 0.020 |
Why?
|
| Parents | 1 | 2014 | 1024 | 0.020 |
Why?
|
| Diet | 1 | 2014 | 1140 | 0.020 |
Why?
|
| Cohort Studies | 2 | 2007 | 4810 | 0.020 |
Why?
|
| Methylphenidate | 1 | 2006 | 58 | 0.020 |
Why?
|
| Data Collection | 1 | 2007 | 381 | 0.020 |
Why?
|
| Central Nervous System Stimulants | 1 | 2006 | 127 | 0.010 |
Why?
|
| Mental Processes | 1 | 2003 | 40 | 0.010 |
Why?
|
| Self Concept | 1 | 2003 | 155 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2017 | 12384 | 0.010 |
Why?
|
| Postpartum Period | 1 | 2003 | 215 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2003 | 729 | 0.010 |
Why?
|
| Fatty Acids | 1 | 2003 | 347 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2018 | 16301 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2003 | 1328 | 0.010 |
Why?
|
| Pediatrics | 1 | 2007 | 1147 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2003 | 2165 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 2003 | 3727 | 0.010 |
Why?
|